Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Income from Continuing Operations (2016 - 2025)

Collegium Pharmaceutical has reported Income from Continuing Operations over the past 10 years, most recently at 16963000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 16963000.0 for Q4 2025, up 35.31% from a year ago — trailing twelve months through Dec 2025 was 62870000.0 (down 9.13% YoY), and the annual figure for FY2025 was 62870000.0, down 9.13%.
  • Income from Continuing Operations for Q4 2025 was 16963000.0 at Collegium Pharmaceutical, down from 31507000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for COLL hit a ceiling of 72843000.0 in Q2 2021 and a floor of 25034000.0 in Q4 2021.
  • Median Income from Continuing Operations over the past 5 years was 12259500.0 (2024), compared with a mean of 11336500.0.
  • Peak annual rise in Income from Continuing Operations hit 7577.45% in 2021, while the deepest fall reached 459.79% in 2021.
  • Collegium Pharmaceutical's Income from Continuing Operations stood at 25034000.0 in 2021, then surged by 71.24% to 7199000.0 in 2022, then skyrocketed by 543.67% to 31940000.0 in 2023, then crashed by 60.75% to 12536000.0 in 2024, then soared by 35.31% to 16963000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 16963000.0 (Q4 2025), 31507000.0 (Q3 2025), and 11983000.0 (Q2 2025) per Business Quant data.